Helen Won

4PUBLICATIONS
45CO-AUTHORS
Respiratory diseasesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 01, 2022
Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers.

Felipe Batalini, Doga C Gulhan, Victor Mao

|Nov 05, 2020
Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant Cancers.

Komal Jhaveri, Matthew T Chang, Dejan Juric

|Oct 02, 2020
TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors.

Emiliano Cocco, Ji Eun Lee, Srinivasaraghavan Kannan

|Dec 07, 2019
Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer.

Lillian M Smyth, Sarina A Piha-Paul, Helen H Won

Pageof 1